Frontlight ResearchEarly access
Ovarian cancer trials in United States
348 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleStudy of AVZO-021 in Patients With Advanced Solid Tumors
- Where
- Cleveland, Dallas, Fairfax, Mineola, New Haven, New York, Oklahoma City, Philadelphia, Portland, Sarasota, Tampa
- Age
- 18 years and over
- People
- 430 worldwide
- Run by
- Avenzo Therapeutics, Inc.
See details and how to joinNCT05867251 - Phase 1/2Taking peopleStudy of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Where
- Birmingham, Boston, Buffalo, Columbus, Houston, Nashville, New York, Oklahoma City, Richmond, Rochester
- Age
- 18 years and over
- People
- 890 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT03564340 · EU 2024-510783-23-00 - No phaseTaking peopleDESTINY-PANTUMOUR04
- Where
- Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
- Age
- 18 years to 130 years
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07124000 - Phase 1/2Taking peopleA Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Where
- Boston, Chicago, Columbus, Detroit, Duarte, Irvine, New York, Orange, Philadelphia, Seattle, Tampa
- Age
- 18 years and over
- People
- 612 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT04590326 · EU 2022-501904-83-00 - Phase 1Taking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- New Have, Santa Monica
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Albuquerque, Boston, Cincinnati, Columbus, Commack, East Brunswick, Grand Rapids, Houston, Kansas City, Los Angeles, Madison, Muncie, Nashville, Portland, San Diego, Santa Rosa
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - Phase 1/2Taking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Aurora, Boston, Dallas, Detroit, Duarte, Fairfax, Grand Rapids, Houston, Indianapolis, Irving, Nashville, New York, Oklahoma City, Orange, Pittsburgh, Sacramento, San Antonio, Sarasota, Stanford, Tampa
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - Phase 2Not yet taking people in United StatesLosartan and Paclitaxel in Platinum Resistant Ovarian Cancer
- Where
- Boston
- Age
- 18 years and over
- People
- 27
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07265739 - Phase 1Taking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Aurora, Beverly Hills, Boston, Chicago, Duarte, Fairfax, Greenville, Houston, Iowa City, Louisville, Miami, Nashville, New Haven, New York, Orange, Orlando, Port Saint Lucie, Santa Monica, Seattle, Washington D.C.
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - No phaseTaking peoplePrehabilitation in High-risk Oncologic Surgery
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 180
- Run by
- Fox Chase Cancer Center
See details and how to joinNCT07638410 - No phaseTaking peopleProspective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer
- Where
- Albuquerque
- Age
- 18 years and over
- People
- 500
- Run by
- New Mexico Cancer Research Alliance
See details and how to joinNCT03943316 - Phase 1Taking peopleFecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04038619 - Phase 1/2Taking peopleBI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Where
- Duarte, New York, Philadelphia
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- BioInvent International AB
See details and how to joinNCT04752826 · EU 2023-509847-29-00 - Phase 1Taking peopleInfusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
- Where
- Tampa
- Age
- 18 years and over
- People
- 10
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT05316129 - Phase 2Taking peopleA Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Where
- Ann Arbor, Austin, Baltimore, Billings, Boston, Charleston, Cincinnati, Columbus, Fairfax, Fort Myers, Fort Wayne, Gainesville, Hackensack, Hershey, Hilliard, Iowa City, Jackson, Los Angeles, Louisville, Miami, Miami Beach, Milwaukee, Minneapolis, Mobile, Morgantown, New York, Omaha, Roanoke, Salt Lake City, San Antonio, San Diego, Shreveport, St Louis, Syracuse, Tyler, Washington D.C., West Palm Beach, Worcester
- Age
- 18 years to 99 years
- People
- 160 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07023627 · EU 2025-521513-14-00 - Phase 2Taking peopleA Study of Isoquercetin in People With Ovarian Cancer
- Where
- Basking Ridge, Boston, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 90
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07303894 - Phase 3Taking peopleMinimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- Where
- Bethlehem, Boston, Cleveland, Durham, Houston, Madison, Miami, Mineola, New York, Weston
- Age
- 18 years and over
- People
- 580 worldwide
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04575935 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Appleton, Aurora, Birmingham, Boston, Broomall, Chandler, Chapel Hill, Cincinnati, Cleveland, Dallas, East Brunswick, Edinburg, Forth Worth, Grand Rapids, Hollywood, Hot Springs, La Jolla, Lakeland, Lewiston, Myrtle Beach, New Orleans, Newport Beach, New York, Philadelphia, Redwood City, Rochester, Rock Hill, Sacramento, Salt Lake City, San Antonio, Shreveport, Toledo, York
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - No phaseTaking peopleBiomarkers of Resiliency In Childhood Cancer Surgery
- Where
- Rochester
- Age
- 3 years to 25 years
- People
- 40
- Run by
- Mayo Clinic
See details and how to joinNCT06674811 - No phaseTaking peopleUterine Lavage to Detect Ovarian Cancer Risk
- Where
- Seattle
- Age
- 18 years and over
- People
- 75
- Run by
- University of Washington
See details and how to joinNCT07772869 - No phaseNot yet taking people in United StatesA Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment
- Where
- Boston
- People
- 30,000
- Run by
- Harvard Medical School (HMS and HSDM)
See details and how to joinNCT07814872 - Phase 2Not yet taking people in United StatesTargeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin
- Where
- Aurora
- Age
- 18 years to 89 years
- People
- 40
- Run by
- University of Colorado, Denver
See details and how to joinNCT07815704 - Phase 1Taking peopleClinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 48
- Run by
- Stanford University
See details and how to joinNCT06646627 - No phaseNot yet taking people in United StatesPITCH - Impacting Hereditary Cancer Testing
- Where
- Lexington
- Age
- 18 years and over
- People
- 200
- Run by
- Rachel Miller
See details and how to joinNCT07090109 - Phase 1/2Not yet taking people in United StatesA Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers
- Where
- Houston
- Age
- 18 years and over
- People
- 138
- Run by
- Advenchen Pharmaceuticals, LLC.
See details and how to joinNCT07811297